to Evaluate the Safety and Efficacy of Pitavastatin in Patients With IFG and Hyperlipidemia (SIPHON)
Randomized, Open-label, Multi-centered Study to Evaluate the Safety and Efficacy of Pitavastatin in Patients With Impaired Fasting Glucose and Hyperlipidemia(Phase 4)
Sponsor: Ajou University School of Medicine
Listed as NCT02056847, this PHASE4 trial focuses on HbA1c Level Associated With Lipid Compositions and remains completed. Sponsored by Ajou University School of Medicine, it has been updated 9 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE4
▶ Show 4 earlier versions
-
Mar 2018 — Jun 2018 [monthly]
Completed PHASE4
Status: Active Not Recruiting → Completed
-
Jun 2017 — Mar 2018 [monthly]
Active Not Recruiting PHASE4
-
Apr 2017 — Jun 2017 [monthly]
Active Not Recruiting PHASE4
Status: Unknown Status → Active Not Recruiting
-
Jan 2017 — Apr 2017 [monthly]
Unknown Status PHASE4
First recorded
Sep 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Ajou University School of Medicine
- Asan Medical Center
- Chonbuk National University Hospital
- Chonnam National University Hospital
- Chungnam National University Hospital
- Dong-A University Hospital
- Eulji University Hospital
- Gangnam Severance Hospital
- Hallym University Medical Center
- JW Pharmaceutical
- Korea University Guro Hospital
- Kyunghee University Medical Center
- Samsung Medical Center
- Seoul National University Bundang Hospital
- Seoul National University Hospital
- Severance Hospital
- The Catholic University of Korea
- Ulsan University Hospital
- Yeungnam University Hospital
For direct contact, visit the study record on ClinicalTrials.gov .